Biomerica Inc (BMRA)

Healthcare | Medical Devices
Income Statement (Quarterly) 2025-08-31 2025-02-28 2024-11-30 2024-08-31
Revenue 1,380,000 1,119,000 1,636,000 1,807,000
Cost of Revenue 956,000 1,100,000 1,199,000 1,518,000
Gross Profit 424,000 19,000 437,000 289,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,330,000 1,012,000 1,173,000 1,360,000
Operating Expenses 1,542,000 1,229,000 1,430,000 1,657,000
Operating Income -1,118,000 -1,210,000 -993,000 -1,368,000
Interest Expense 0 0 0 0
Income Before Tax 5,000 -1,167,000 -953,000 -1,312,000
Income Tax Expense 3,000 -4,000 -3,000 4,000
Net Income 2,000 -1,163,000 -950,000 -1,316,000
Per Share
EPS 0.00 -0.07 -0.06 -0.08
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Revenue 5,311,000 5,415,000 5,339,000 18,871,409 7,199,027
Cost of Revenue 4,813,000 4,804,000 4,893,000 15,893,991 6,702,046
Gross Profit 498,000 611,000 446,000 2,977,418 496,981
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 4,612,000 5,487,000 6,085,000 5,698,958 4,608,950
Operating Expenses 5,635,000 6,978,000 7,669,000 7,511,382 7,019,456
Operating Income -5,137,000 -6,367,000 -7,223,000 -4,533,964 -6,522,475
Interest Expense 0 0 0 26,639 367
Income Before Tax -4,972,000 -5,936,000 -7,089,000 -4,507,325 -6,455,979
Income Tax Expense 1,000 42,000 51,000 23,719 13,057
Net Income -4,973,000 -5,978,000 -7,140,000 -4,531,044 -6,469,036
Per Share
EPS -2.16 -0.36 -0.50 -0.36 -0.54
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Assets
Cash and Cash Equivalents 2,399,000 4,170,000 9,719,000 5,916,983
Short Term Investments 0 0 0 0
Net Receivables 731,000 947,000 722,000 773,818
Inventory 1,490,000 2,376,000 2,056,000 2,416,000
Total Current Assets 4,875,000 7,731,000 12,797,000 9,427,531
Property Plant Equipment 564,000 943,000 1,248,000 1,515,474
Goodwill and Intangibles 228,000 212,000 165,000 170,000
Total Assets 5,945,000 9,254,000 14,454,000 11,374,280
Liabilities
Account Payables 295,000 288,000 344,000 736,000
Short Term Debt 358,000 326,000 297,000 341,296
Total Current Liabilities 1,740,000 2,204,000 1,945,000 2,011,282
Long Term Debt 100,000 459,000 785,000 1,038,284
Total Liabilities 1,840,000 2,663,000 2,730,000 3,049,566
Shareholders Equity
Retained Earnings -53,168,000 -48,195,000 -42,217,000 -35,077,379
Total Shareholders Equity 4,105,000 6,591,000 11,724,000 8,324,714
Balance Sheet (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Assets
Cash and Cash Equivalents 2,399,000 4,170,000 9,719,000 5,916,983 4,199,311
Short Term Investments 0 0 0 0 0
Net Receivables 731,000 947,000 722,000 773,818 1,455,051
Inventory 1,490,000 2,376,000 2,056,000 2,416,000 3,206,000
Total Current Assets 4,875,000 7,731,000 12,797,000 9,427,531 9,230,907
Property Plant Equipment 564,000 943,000 1,248,000 1,515,474 1,863,601
Goodwill and Intangibles 228,000 212,000 165,000 170,000 294,830
Total Assets 5,945,000 9,254,000 14,454,000 11,374,280 11,818,813
Liabilities
Account Payables 295,000 288,000 344,000 736,000 431,621
Short Term Debt 358,000 326,000 297,000 341,296 327,944
Total Current Liabilities 1,740,000 2,204,000 1,945,000 2,011,282 1,300,220
Long Term Debt 100,000 459,000 785,000 1,038,284 1,291,570
Total Liabilities 1,840,000 2,663,000 2,730,000 3,049,566 2,591,790
Shareholders Equity
Retained Earnings -53,168,000 -48,195,000 -42,217,000 -35,077,379 -28,394,768
Total Shareholders Equity 4,105,000 6,591,000 11,724,000 8,324,714 9,227,023
Cash Flow Statement (Quarterly) 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Operating Activities
Net Income -4,973,000 -5,978,000 -7,140,000 -4,531,044
Depreciation & Amortization 400,000 374,000 351,000 594,821
Stock Based Compensation 460,000 837,000 1,185,000 1,260,195
Change in Working Capital 268,000 -625,000 -38,000 2,914,645
Operating Cash Flow -3,841,000 -5,361,000 -5,474,000 -480,532
Investing Activities
Capital Expenditure -37,000 -115,000 -78,000 -170,336
Investments -37,000 -51,000 -78,000 -170,336
Investing Cash Flow -37,000 -115,000 -78,000 -170,336
Financing Activities
Debt Repayment 0 0 0 0
Common Stock Issued/Repurchased 2,143,000 -81,000 9,309,000 2,317,160
Dividends Paid 0 0 0 0
Financing Cash Flow 2,111,000 -81,000 9,390,000 2,394,520
Summary
Free Cash Flow -3,878,000 -5,476,000 -5,552,000 -650,868
Net Change in Cash -1,770,000 -5,549,000 3,802,000 1,717,672
Cash Flow Statement (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Operating Activities
Net Income -4,973,000 -5,978,000 -7,140,000 -4,531,044 -6,469,036
Depreciation & Amortization 400,000 374,000 351,000 594,821 375,855
Stock Based Compensation 460,000 837,000 1,185,000 1,260,195 377,391
Change in Working Capital 268,000 -625,000 -38,000 2,914,645 -1,852,986
Operating Cash Flow -3,841,000 -5,361,000 -5,474,000 -480,532 -5,251,748
Investing Activities
Capital Expenditure -37,000 -115,000 -78,000 -170,336 -295,583
Investments -37,000 -51,000 -78,000 -170,336 -135,856
Investing Cash Flow -37,000 -115,000 -78,000 -170,336 -295,583
Financing Activities
Debt Repayment 0 0 0 0 0
Common Stock Issued/Repurchased 2,143,000 -81,000 9,309,000 2,317,160 1,011,475
Dividends Paid 0 0 0 0 0
Financing Cash Flow 2,111,000 -81,000 9,390,000 2,394,520 1,113,730
Summary
Free Cash Flow -3,878,000 -5,476,000 -5,552,000 -650,868 -5,547,331
Net Change in Cash -1,770,000 -5,549,000 3,802,000 1,717,672 -4,441,716